Dr. Michael Posey, MD

NPI: 1194700146
Total Payments
$12,226
2024 Payments
$1,373
Companies
55
Transactions
650
Medicare Patients
2,540
Medicare Billing
$378,791

Payment Breakdown by Category

Food & Beverage$12,109 (99.0%)
Education$117.20 (1.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $12,109 646 99.0%
Education $117.20 4 1.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $1,520 80 $0 (2024)
Amgen Inc. $982.45 53 $0 (2024)
Merck Sharp & Dohme LLC $970.23 77 $0 (2024)
Novartis Pharmaceuticals Corporation $781.23 45 $0 (2024)
AstraZeneca Pharmaceuticals LP $735.82 28 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $639.66 31 $0 (2023)
Lilly USA, LLC $627.82 23 $0 (2024)
Avanir Pharmaceuticals, Inc. $431.42 21 $0 (2022)
ABBVIE INC. $416.61 28 $0 (2024)
SANOFI-AVENTIS U.S. LLC $402.54 25 $0 (2020)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,373 55 AstraZeneca Pharmaceuticals LP ($228.13)
2023 $1,877 80 Novo Nordisk Inc ($437.01)
2022 $1,236 64 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($163.34)
2021 $1,581 90 AbbVie Inc. ($272.65)
2020 $1,216 74 Novo Nordisk Inc ($243.97)
2019 $1,064 56 Salix Pharmaceuticals, a division of Bausch Health US, LLC ($215.74)
2018 $1,703 92 Daiichi Sankyo Inc. ($229.87)
2017 $2,176 139 Merck Sharp & Dohme Corporation ($281.54)

All Payment Transactions

650 individual payment records from CMS Open Payments — Page 1 of 26

Date Company Product Nature Form Amount Type
12/19/2024 E.R. Squibb & Sons, L.L.C. CAMZYOS (Drug) Food and Beverage Cash or cash equivalent $126.11 General
Category: Cardiovascular
12/10/2024 Hikma Pharmaceuticals USA Ryaltris (Drug) Food and Beverage In-kind items and services $13.88 General
Category: Pulmonary/Respiratory Diseases
12/05/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $13.69 General
Category: Oncology
11/07/2024 Abbott Laboratories Food and Beverage In-kind items and services $22.53 General
Category: Diabetes Care
11/04/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $18.10 General
Category: Inflammation
10/31/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $16.55 General
Category: CARDIOVASCULAR
10/22/2024 Amgen Inc. EVENITY (Biological) Food and Beverage In-kind items and services $14.27 General
Category: Bone Health
10/02/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $13.99 General
Category: CARDIOVASCULAR
09/26/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage In-kind items and services $23.49 General
Category: Endocrinology
09/24/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $20.96 General
Category: Obesity
09/24/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $15.85 General
Category: Inflammation
09/11/2024 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $22.95 General
Category: Cardiovascular and Metabolism
09/03/2024 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $21.06 General
Category: Diabetes
08/26/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $16.78 General
Category: Cardiology/Vascular Diseases
08/20/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $14.45 General
Category: ANTILIPEMIC AGENTS
08/19/2024 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $15.45 General
Category: CARDIOVASCULAR
08/14/2024 Novo Nordisk Inc Wegovy (Drug) Food and Beverage In-kind items and services $15.42 General
Category: Obesity
08/08/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $26.41 General
Category: Inflammation
08/05/2024 Exact Sciences Corporation Cologuard Collection Kit (Device) Food and Beverage In-kind items and services $16.23 General
Category: Oncology
07/29/2024 PFIZER INC. PAXLOVID (Drug) Food and Beverage In-kind items and services $14.88 General
Category: INFECTIOUS DISEASES
07/25/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $69.28 General
Category: Cardiology/Vascular Diseases
07/18/2024 Corcept Therapeutics Korlym (Drug) Food and Beverage In-kind items and services $22.29 General
Category: Endocrinology
07/17/2024 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $24.90 General
Category: Diabetes
07/10/2024 ABBVIE INC. TEFLARO (Drug), DALVANCE Food and Beverage In-kind items and services $22.63 General
Category: ANTI-INFECTIVE
07/01/2024 Esperion Therapeutics, Inc. NEXLETOL (Drug) Food and Beverage In-kind items and services $17.20 General
Category: ANTILIPEMIC AGENTS

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 20 759 1,766 $188,990 $102,918
2022 12 613 1,432 $162,764 $92,092
2021 9 547 1,151 $145,849 $85,259
2020 12 621 1,506 $185,134 $98,523
Total Patients
2,540
Total Services
5,855
Medicare Billing
$378,791
Procedure Codes
53

All Medicare Procedures & Services

53 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 59 376 $38,728 $22,130 57.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 159 375 $37,500 $21,429 57.1%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 128 128 $17,920 $15,267 85.2%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 61 78 $23,322 $9,984 42.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 65 102 $15,300 $8,696 56.8%
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 39 92 $13,800 $8,148 59.0%
99238 Hospital discharge day management, 30 minutes or less Facility 2023 54 66 $9,900 $3,953 39.9%
99458 Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes Office 2023 21 111 $6,105 $3,231 52.9%
99457 Management using the results of remote vital sign monitoring per calendar month, first 20 minutes Office 2023 22 65 $4,875 $2,309 47.4%
99454 Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days Office 2023 16 48 $3,600 $1,682 46.7%
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 12 25 $2,500 $1,152 46.1%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 16 16 $2,400 $1,070 44.6%
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month Office 2023 11 29 $2,175 $1,010 46.4%
99239 Hospital discharge day management, more than 30 minutes Facility 2023 11 11 $1,815 $933.68 51.4%
69210 Removal of impacted ear wax Office 2023 13 15 $2,250 $519.60 23.1%
96372 Injection of drug or substance under skin or into muscle Office 2023 19 46 $2,530 $465.34 18.4%
90674 Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free Office 2023 11 11 $550.00 $368.39 67.0%
G0008 Administration of influenza virus vaccine Office 2023 11 11 $550.00 $312.84 56.9%
99453 Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment Office 2023 15 15 $675.00 $200.10 29.6%
J0696 Injection, ceftriaxone sodium, per 250 mg Office 2023 16 146 $2,495 $57.64 2.3%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 46 418 $43,054 $22,688 52.7%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 135 317 $31,700 $19,654 62.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 115 175 $26,250 $14,902 56.8%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 111 111 $15,540 $13,831 89.0%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 46 64 $19,136 $9,572 50.0%

About Dr. Michael Posey, MD

Dr. Michael Posey, MD is a Internal Medicine healthcare provider based in Germantown, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194700146.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Posey, MD has received a total of $12,226 in payments from pharmaceutical and medical device companies, with $1,373 received in 2024. These payments were reported across 650 transactions from 55 companies. The most common payment nature is "Food and Beverage" ($12,109).

As a Medicare-enrolled provider, Posey has provided services to 2,540 Medicare beneficiaries, totaling 5,855 services with total Medicare billing of $378,791. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Germantown, TN
  • Active Since 12/13/2005
  • Last Updated 04/17/2018
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1194700146

Products in Payments

  • Ozempic (Drug) $764.56
  • FARXIGA (Drug) $467.45
  • ENTRESTO (Drug) $417.29
  • BELSOMRA (Drug) $394.48
  • CYCLOSET (Drug) $382.25
  • LEQVIO (Drug) $363.94
  • Otezla (Drug) $360.68
  • NUEDEXTA (Drug) $357.80
  • DALVANCE (Drug) $333.98
  • XARELTO (Drug) $306.91
  • JANUVIA (Drug) $257.24
  • Morphabond ER (Drug) $252.17
  • XIFAXAN (Drug) $242.49
  • SOLIQUA (Drug) $239.85
  • ELIQUIS (Drug) $236.18
  • Vascepa (Drug) $233.67
  • Prolia (Biological) $224.74
  • TRULICITY (Drug) $224.67
  • MOUNJARO (Drug) $209.60
  • Rybelsus (Drug) $208.75

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Germantown